|
Pelaez-Cruz P, Lopez Jornet P, Tatullo M, Pons-Fuster Lopez E. Epigallocatechin-3-gallate improves the biocompatibility of bone substitutes in dental pulp stem cells. Ann Anat. 2023 Feb;246:152045. doi: 10.1016/j.aanat.2022.152045. Epub 2022 Dec 28. PubMed PMID: 36584903.
AÑO: 2023; IF: 2.0
|
36584903
|
Nicolas-Rodriguez E, Garcia-Martinez A, Molino-Pagan D, Marin-Martinez L, Pons-Fuster E, Lopez-Jornet P. Thermography as a Non-Ionizing Quantitative Tool for Diagnosing Burning Mouth Syndrome: Case-Control Study. Int J Environ Res Public Health. 2022 Jul 22;19(15):8903. doi: 10.3390/ijerph19158903. PubMed PMID: 35897273; PubMed Central PMCID: PMC9329975.
AÑO: 2022; IF: 4.614
|
|
Salinas-Gilabert C, Gomez Garcia F, Galera Molero F, Pons-Fuster E, Vander Beken S, Lopez Jornet P. Photodynamic Therapy, Photobiomodulation and Acetonide Triamcinolone 0.1% in the Treatment of Oral Lichen Planus: A Randomized Clinical Trial. Pharmaceutics. 2022 Dec 22;15(1):30. doi: 10.3390/pharmaceutics15010030. PubMed PMID: 36678659; PubMed Central PMCID: PMC9862179.
AÑO: 2022; IF: 6.525
|
|
Ferrandez-Pujante A, Pons-Fuster E, Lopez-Jornet P. Efficacy of Photobiomodulation in Reducing Symptomatology and Improving the Quality of Life in Patients with Xerostomia and Hyposalivation: A Randomized Controlled Trial. J Clin Med. 2022 Jun 14;11(12):3414. doi: 10.3390/jcm11123414. PubMed PMID: 35743485; PubMed Central PMCID: PMC9225194.
AÑO: 2022; IF: 4.964
|
|
Castillo-Felipe C, Tvarijonaviciute A, Lopez-Arjona M, Pardo-Marin L, Pons-Fuster E, Lopez-Jornet P. Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome. J Clin Med. 2022 Apr 29;11(9):2516. doi: 10.3390/jcm11092516. PubMed PMID: 35566642; PubMed Central PMCID: PMC9101769.
AÑO: 2022; IF: 4.964
|